Study Summary
This trialshows HSK3486 is as effective as propofol for inducing general anesthesia in adults undergoing elective surgery.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: 15 minutes from end of drug administration
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Propofol
1 of 2
HSK3486
1 of 2
Active Control
Experimental Treatment
399 Total Participants · 2 Treatment Groups
Primary Treatment: HSK3486 · No Placebo Group · Phase 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 99 · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there short-term or long-term dangers to taking HSK3486?
"Although this is only a phase 3 trial, there is some evidence of efficacy and HSK3486's safety has been corroborated multiple times. Therefore, it receives a score of 3." - Anonymous Online Contributor
Are there any restrictions on who is allowed to enroll in this research project?
"Eligible participants for this study must be able to undergo general anesthesia and be between 18-99 years old. There is a total of 399 slots for this clinical trial." - Anonymous Online Contributor
Is this clinical trial restricted to people under the age of 20?
"The age group that this study is targeting is individuals who are over 18 and under 99 years old." - Anonymous Online Contributor